BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18816610)

  • 1. Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer.
    Moran MS; Yang Q; Harris LN; Jones B; Tuck DP; Haffty BG
    Cancer; 2008 Nov; 113(9):2565-74. PubMed ID: 18816610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome.
    Lund MJ; Mosunjac M; Davis KM; Gabram-Mendola S; Rizzo M; Bumpers HL; Hearn S; Zelnak A; Styblo T; O'Regan RM
    Cancer; 2012 Feb; 118(3):788-96. PubMed ID: 21720988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers.
    Purrington KS; Gorski D; Simon MS; Hastert TA; Kim S; Rosati R; Schwartz AG; Ratnam M
    Breast Cancer Res Treat; 2020 May; 181(1):145-154. PubMed ID: 32236827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does race predict survival for women with invasive breast cancer?
    Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
    Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis for mammographically occult, early-stage breast cancer patients treated with breast-conservation therapy.
    Yang TJ; Yang Q; Haffty BG; Moran MS
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):79-84. PubMed ID: 19619957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.
    Rueth NM; Black DM; Limmer AR; Gabriel E; Huo L; Fornage BD; Dogan BE; Chavez-MacGregor M; Yi M; Hunt KK; Strom EA
    Ann Surg Oncol; 2015 Jan; 22(1):90-5. PubMed ID: 25249256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for supraclavicular lymph node recurrence in N1 breast cancer patients.
    Kong M; Hong SE
    Asian Pac J Cancer Prev; 2013; 14(4):2509-14. PubMed ID: 23725165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
    Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
    Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of early distant metastasis in women with breast cancer.
    Rosa Mendoza ES; Moreno E; Caguioa PB
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):645-52. PubMed ID: 23283528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations.
    Wright N; Xia J; Cantuaria G; Klimov S; Jones M; Neema P; Il'yasova D; Krishnamurti U; Li X; Reid MD; Gupta M; Rida PC; Osan R; Aneja R
    PLoS One; 2017; 12(1):e0170095. PubMed ID: 28085947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of vascular endothelial growth factor as a prognostic marker for local relapse in early-stage breast cancer patients treated with breast-conserving therapy.
    Moran MS; Yang Q; Goyal S; Harris L; Chung G; Haffty BG
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1236-43. PubMed ID: 21093162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer.
    Caudle AS; Gonzalez-Angulo AM; Hunt KK; Pusztai L; Kuerer HM; Mittendorf EA; Hortobagyi GN; Meric-Bernstam F
    Ann Surg Oncol; 2011 Apr; 18(4):932-8. PubMed ID: 21061075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in disease presentation, management techniques, treatment outcome, and toxicities in African-American women with early stage breast cancer treated with breast-conserving therapy.
    Vicini F; Jones P; Rivers A; Wallace M; Mitchell C; Kestin L; Jaiyesimi I; Dekhne N; Martinez A
    Cancer; 2010 Jul; 116(14):3485-92. PubMed ID: 20564071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.
    Michieletto S; Saibene T; Evangelista L; Barbazza F; Grigoletto R; Rossi G; Ghiotto C; Bozza F
    Breast; 2014 Feb; 23(1):19-25. PubMed ID: 24189101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.
    McBride R; Hershman D; Tsai WY; Jacobson JS; Grann V; Neugut AI
    Cancer; 2007 Sep; 110(6):1201-8. PubMed ID: 17701948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.